Isomorphic Labs secures $5B to accelerate AI drug design
According to a post by Demis Hassabis on X, Isomorphic Labs raised $5B to advance AI-driven, first-principles drug design aimed at cutting time and cost in new medicine discovery.
SourceAnalysis
On November 17 2026 Demis Hassabis announced five billion dollars in funding for IsomorphicLabs to speed up its mission of solving disease through artificial intelligence according to the post.
The company is advancing AI systems that redesign drug discovery from first principles to shorten development timelines and lower costs for new medicines.
Demis Hassabis
@demishassabisNobel Laureate and DeepMind CEO pursuing AGI development while transforming drug discovery at Isomorphic Labs.